MIDAS and HIT-6 Questionnaires Versus Headache Diaries for Monitoring Treatment Response to Erenumab in Migraine: A REFORM Study. [PDF]
Thuraiaiyah J +5 more
europepmc +1 more source
Multimodal serum and MRI signatures of neuroaxonal injury in high-frequency migraine. [PDF]
Gallardo VJ +10 more
europepmc +1 more source
Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine. [PDF]
Berger CT +5 more
europepmc +1 more source
The role of non-coding RNAs in the pathogenesis of migraine: from molecular insights to potential biomarkers. [PDF]
Zhang L +5 more
europepmc +1 more source
Efficacy of Erenumab in Patients With Treatment-Resistant Chronic Migraine and Medication Overuse Headache. [PDF]
Binfalah MF +3 more
europepmc +1 more source
CGRP-Targeting Therapies in Vestibular Migraine: A Synthesis of Observational Evidence with Direction-of-Effect Analysis. [PDF]
Ciubotaru A +13 more
europepmc +1 more source
Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad. [PDF]
Yang X, Yang W, Chen N, Li D, Xu Y.
europepmc +1 more source
A Real-World Study of CGRP Monoclonal Antibodies for Migraine: Long-Term Effectiveness and Treatment Adherence. [PDF]
Suzuki K +6 more
europepmc +1 more source
Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study. [PDF]
Paiva da Silva Lima G +11 more
europepmc +1 more source

